- Home
- VAC vs DYN Comparison
VAC vs DYN Comparison
Compare VAC & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VAC
- DYN
- Stock Information
- Founded
- VAC 1984
- DYN 1984
- Country
- VAC United States
- DYN United States
- Employees
- VAC N/A
- DYN N/A
- Industry
- VAC Real Estate
- DYN Medicinal Chemicals and Botanical Products
- Sector
- VAC Finance
- DYN Health Care
- Exchange
- VAC Nasdaq
- DYN Nasdaq
- Market Cap
- VAC 1.6B
- DYN 1.9B
- IPO Year
- VAC N/A
- DYN 2020
- Fundamental
- Price
- VAC $46.62
- DYN $21.17
- Analyst Decision
- VAC Buy
- DYN Strong Buy
- Analyst Count
- VAC 7
- DYN 15
- Target Price
- VAC $67.86
- DYN $36.53
- AVG Volume (30 Days)
- VAC 710.1K
- DYN 3.2M
- Earning Date
- VAC 11-05-2025
- DYN 11-05-2025
- Dividend Yield
- VAC 6.78%
- DYN N/A
- EPS Growth
- VAC N/A
- DYN N/A
- EPS
- VAC 4.58
- DYN N/A
- Revenue
- VAC $3,358,000,000.00
- DYN N/A
- Revenue This Year
- VAC $56.59
- DYN N/A
- Revenue Next Year
- VAC $3.49
- DYN N/A
- P/E Ratio
- VAC $10.18
- DYN N/A
- Revenue Growth
- VAC 5.13
- DYN N/A
- 52 Week Low
- VAC $44.58
- DYN $6.36
- 52 Week High
- VAC $99.42
- DYN $31.32
- Technical
- Relative Strength Index (RSI)
- VAC 27.71
- DYN 59.60
- Support Level
- VAC $45.12
- DYN $18.20
- Resistance Level
- VAC $47.70
- DYN $22.00
- Average True Range (ATR)
- VAC 2.86
- DYN 1.77
- MACD
- VAC -1.28
- DYN -0.30
- Stochastic Oscillator
- VAC 8.83
- DYN 56.68
About VAC Marriott Vacations Worldwide Corporation
Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.